Viking Therapeutics, Inc.·4

Nov 8, 6:22 PM ET

MACARTNEY LAWSON 4

4 · Viking Therapeutics, Inc. · Filed Nov 8, 2024

Insider Transaction Report

Form 4
Period: 2024-11-08
Transactions
  • Sale

    Common Stock, par value $0.00001 per share

    2024-11-08$68.67/sh2,000$137,33347,965 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-082,00020,000 total
    Exercise: $5.80From: 2022-01-04Exp: 2031-01-04Common Stock (2,000 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.00001 per share

    2024-11-08$5.80/sh+2,000$11,60049,965 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4